DCTH · NASDAQ · Medical - Devices

Delcath Systems (DCTH)

Commercializing HEPZATO in the United States and CHEMOSAT in Europe for liver-directed oncology.

$16.45
After hours+0.07 (+0.43%)
At close$16.38(+1.68%)